Practical Guidelines to Interpret Plasma Concentrations of Antiretroviral Drugs
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 43 (13) , 845-853
- https://doi.org/10.2165/00003088-200443130-00002
Abstract
Several relationships have been reported between antiretroviral drug concentrations and the efficacy of treatment, and toxicity. Therefore, therapeutic drug monitoring (TDM) may be a valuable tool in...Keywords
This publication has 47 references indexed in Scilit:
- Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1–infected childrenThe Journal of Pediatrics, 2004
- Once‐Daily versus Twice‐Daily Lopinavir/Ritonavir in Antiretroviral‐Naive HIV‐Positive Patients: A 48‐Week Randomized Clinical TrialThe Journal of Infectious Diseases, 2004
- Low Nevirapine Plasma Concentrations Predict Virological Failure in an Unselected HIV-1-Infected PopulationClinical Pharmacokinetics, 2003
- Drug Interactions Between Antiretroviral Drugs and Comedicated AgentsClinical Pharmacokinetics, 2003
- Therapeutic Drug MonitoringDrugs, 2003
- Does an Increase in Nevirapine Plasma Levels Cause Complete Virologic Suppression in Patients Experiencing Early Virologic Failure?HIV Research & Clinical Practice, 2002
- Clinical use of lopinavir/ritonavir in a salvage therapy settingAIDS, 2002
- HEPATOTOXICITY FOLLOWING NEVIRAPINE-CONTAINING REGIMENS IN HIV-1-INFECTED INDIVIDUALSPharmacological Research, 2002
- Antiviral Effect and Pharmacokinetic Interaction between Nevirapine and Indinavir in Persons Infected with Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1999
- SaquinavirDrugs, 1996